Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung

Immunological Reviews

Volumn 177, Issue , 2000, Pages 31-42

  Gutierrez Ramos, J C ^a   Lloyd, C ^a   Kapsenberg, M L ^a   Gonzalo, J A ^a   Coyle, A J ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; EOTAXIN; FUNCTIONAL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CHEMOTAXIS; EFFECTOR CELL; EOSINOPHIL; INFLAMMATION; LUNG DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; TH2 CELL;

EID: 0033647212     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17713.x     Document Type: Review

References (66)

1. Chemokines
2. Biology and biochemistry of the chemokines; a family of chemotactic and inflammatory cytokines
3. Interleukin-8 and related chemotactic cytokines; CXC and CC chemokines
4. Through the looking glass: The diverse in vivo activities of chemokines
5. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
6. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
7. Molecular cloning and structure of a pre-B-cell growth stimulating factor
8. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
9. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
10. The chemokine system: Redundancy for robust outputs
11. Chemokines and asthma: Redundancy of function or a coordinated effort?
12. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model
13. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma
14. The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity
15. The eosinophil and bronchial asthma: Current understanding
16. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness
17. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
18. Eosinophil recruitment to the lung in a murine model of allergic inflammation: The role of T cells, chemokines and endothelial adhesion receptors
19. Basophil influx occurs after nasal antigen challenge effects of tropical corticosteroid pretreatment
20. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
21. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
22. Heterogeneity of human mast cells based on cytokine content
23. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
24. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma
25. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
26. Human alveolar macrophages produce leukotriene B4
27. Secretory products of macrophages
28. Identification and characterization of a monocyte-derived neutrophil activating peptide in corticosteroid resistant bronchial asthma. Identification and characterization of a monocyte-derived neutrophil activating peptide in corticosteroid resistant bronchial asthma
29. Activated-T lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma
30. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma
31. Mechanism of eosinophilia. II. Role of the lymphocytes
32. Effects of tumor necrosis factor, lipopolysaccharide and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo
33. Identification of activated T-lymphocytes and eosinophil in bronchial biopsies in stable atopic asthmatics
34. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation
35. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
36. IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy
37. Th-1 and Th-2 type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
38. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma
39. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
40. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells
41. Eotaxin expression and eosinophilic inflammation in asthma
42. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways
43. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response
44. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila
45. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
46. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
47. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
48. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
49. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model
50. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
51. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea
52. Chemokine receptors and T cells chemotaxis
53. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
54. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells and natural killer cells
55. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
56. Monocyte-derived chemokine is involved in lung inflammation and airway hyperreactivity
57. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells
58. CC3/Eotaxin is followed by CCR4/MDC in the recruitment of Th2 cells in vivo
59. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
60. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry
61. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor1 (SDF-1)
62. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins
63. Critical involvement of the chemotactic axis CXCR4/SDF1 in the inflammatory component of allergic airway disease
64. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells
65. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7
66. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T-cells